2 safe FTSE 100 shares with dividend yields above 4%

Are these the best FTSE 100 shares for dividends and safety?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Today, I’m taking a look at two FTSE 100 shares that I believe offer solid long-term dividend growth potential.

Regulated monopoly

First up is National Grid (LSE: NG), the UK’s largest listed utility company. With a relatively low beta of just 0.48, its shares tend to be less volatile than the wider index, which suggest that National Grid is a less risky investment.

One of the biggest advantages for National Grid, and which explains why it has such a low-risk business model, is the exceptionally high initial costs needed to build infrastructure for electricity transmission and gas distribution. This makes National Grid a natural monopoly, which means it faces no competition whatsoever.

Instead, nearly all of its revenues are regulated by Ofgem, via the RIIO regulatory framework, which determines how much the company is allowed to earn on investments made to its infrastructure assets. These revenues are linked to RPI inflation and don’t depend on volumes or commodity prices. This results in the company generating stable earnings and cash flows year-on-year, and means its shares have staying power.

The company is undergoing a major transformation, which should reinforce its status as a ‘shareholder friendly’ company. In December, the company agreed to sell a 61% stake in its gas distribution network, which should allow it to focus on its faster-growing electricity transmission business.

The sale received the green light from the European Commission last week, which means the deal is expected to close in the coming weeks. And once completed, National Grid intends to return £4bn of its net proceeds to shareholders via a combination of a special dividend and share buybacks. Additionally, National Grid’s rate of earnings growth should pick up following the deal, and that would be further good news for dividend investors.

Annual dividends per share have increased more than 60% over the past decade, with a compound annual growth rate (CAGR) of 5.0% over the past 10 years. Looking forward, National Grid has pledged to grow ordinary dividends at least in line with RPI inflation for the foreseeable future, following a share consolidation later this year, intended to reflect its smaller asset base following the sale of its gas network.

At a current price of 995p a share, National Grid has a dividend yield of 4.5%.

Diversified business model

GlaxoSmithKline‘s (LSE: GSK) dividend safety comes from a combination of two factors: the non-cyclical nature of demand for pharmaceutical products and the company’s unique diversified business model.

In addition to the traditional pharmaceutical business, GSK owns a large consumer healthcare businesses, which generates more than a quarter of its revenues, and a sizeable vaccines business, which accounts for another 16% of group revenues. Together, these two businesses account for a growing proportion of GSK’s revenues and a majority of its earnings growth in recent years.

An anticipated 9% earnings rise at GSK this year gives its shares a reasonable forward P/E rating of 15.4 times. And this would fall to 14.7 times in 2018 on forecasts of further earnings improvement of 4%. With an improving earnings outlook and strong diversification, I reckon GSK represents a great pick for long-term income investors.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Jack Tang has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »